VONOPRAZAN-AMOXICILLIN DUAL THERAPY VERSUS BISMUTH-BASED QUADRUPLE THERAPY FOR TREATMENT OF HELICOBACTER PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Abosheaishaa, Hazem
Elsayed, Hesham
Harfoush, Mohamed K.
Abusuliman, Mohammed
Abdelhalim, Omar
Mohamed, Islam
Sethi, Arshia
El Haddad, Islam M.
Salem, Ahmed
Nassar, Mahmoud
Karna, Rahul
Bilal, Mohammad
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1384
引用
收藏
页码：S439 / S439
页数：1
相关论文
共 50 条
  • [1] Vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
    Zhou, Ben-Gang
    Jiang, Xin
    Ding, Yan-Bing
    She, Qiang
    Li, Yao-Yao
    HELICOBACTER, 2024, 29 (01)
  • [2] Efficacy and safety of vonoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for patients with Helicobacter pylori infection: a meta-analysis
    Li, Xiao
    Jiang, Cheng
    Su, Yuwen
    Gao, Ruiyun
    Yang, Peijun
    Qin, Yuechen
    Zou, Yue
    Liang, Weiming
    Quan, Jieru
    Pan, Liying
    FRONTIERS IN MICROBIOLOGY, 2025, 16
  • [3] The efficacy and safety of vonoprazan-amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis
    Feng, Jia-Hui
    Cheng, Jie
    Lao, Yao-Jia
    Huang, Kai
    Mou, Juan-Li
    Hu, Fan
    Lin, Meng-Lu
    Lin, Jun
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [4] Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials
    Zhou, Ben-Gang
    Mei, Yu-Zhou
    Jiang, Xin
    Zheng, Ai-Jing
    Ding, Yan-Bing
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2023, 29 (06): : 347 - 357
  • [5] Vonoprazan and amoxicillin dual therapy as the first-line treatment of Helicobacter pylori infection: A systematic review and meta-analysis
    Du, Ren-Chun
    Hu, Yu-Xin
    Ouyang, Yaobin
    Ling, Li-Xiang
    Xu, Jing-Yuan
    Sa, Rina
    Liu, Xiao-Shun
    Hong, Jun-Bo
    Zhu, Yin
    Lu, Nong-Hua
    Hu, Yi
    HELICOBACTER, 2024, 29 (01)
  • [6] Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy
    Qian, Hai-Sheng
    Li, Wen-Jie
    Dang, Yi-Ni
    Li, Lu-Rong
    Xu, Xiao-Bing
    Yuan, Lin
    Zhang, Wei-Feng
    Yang, Zhen
    Gao, Xin
    Zhang, Min
    Li, Xuan
    Zhang, Guo-Xin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (04): : 627 - 634
  • [7] The Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Infection: A Systematic Review and Network Meta-Analysis
    Liu, Ligang
    Li, Fang
    Shi, Hekai
    Nahata, Milap C.
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [8] High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment A systematic review and meta-analysis
    Yang, Xue
    Wang, Jin-Xia
    Han, Sheng-Xi
    Gao, Cai-Ping
    MEDICINE, 2019, 98 (07)
  • [9] Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
    Ouyang, Yaobin
    Wang, Minghui
    Xu, Yu-Ling
    Zhu, Yin
    Lu, Nong-Hua
    Hu, Yi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (09) : 1666 - 1672
  • [10] Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:: A meta-analysis
    Saad, RJ
    Schoenfeld, P
    Kim, HM
    Chey, WD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (03): : 488 - 496
12345